SRPT logo

Sarepta Therapeutics, Inc. (SRPT) Return On Equity

Annual ROE:

19.71%+105.86%(+122.88%)
December 31, 2024

Summary

  • As of today, SRPT annual return on equity is 19.71%, with the most recent change of +105.86% (+122.88%) on December 31, 2024.
  • During the last 3 years, SRPT annual ROE has risen by +69.28% (+139.76%).
  • SRPT annual ROE is now at all-time high.

Performance

SRPT ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTprofitability metrics

Quarterly ROE:

-20.67%-16.09%(-351.31%)
September 30, 2025

Summary

  • As of today, SRPT quarterly return on equity is -20.67%, with the most recent change of -16.09% (-351.31%) on September 30, 2025.
  • Over the past year, SRPT quarterly ROE has dropped by -33.15% (-265.62%).
  • SRPT quarterly ROE is now -199.23% below its all-time high of 20.83%, reached on December 31, 2024.

Performance

SRPT Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

SRPT ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+122.9%-265.6%
3Y3 Years+139.8%+80.3%
5Y5 Years+125.5%+66.3%

SRPT ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+118.4%-199.2%+88.5%
5Y5-Yearat high+118.4%-199.2%+88.5%
All-TimeAll-Timeat high+106.4%-199.2%+95.3%

SRPT ROE History

DateAnnualQuarterly
Sep 2025
-
-20.67%(-351.3%)
Jun 2025
-
-4.58%(+78.1%)
Mar 2025
-
-20.94%(-200.5%)
Dec 2024
19.71%(+122.9%)
20.83%(+66.9%)
Sep 2024
-
12.48%(+132.4%)
Jun 2024
-
5.37%(+156.9%)
Mar 2024
-
2.09%(+102.7%)
Dec 2023
-86.15%(+19.6%)
-77.39%(+32.0%)
Sep 2023
-
-113.84%(+24.8%)
Jun 2023
-
-151.46%(+15.5%)
Mar 2023
-
-179.19%(-69.5%)
Dec 2022
-107.16%(-116.2%)
-105.72%(-0.7%)
Sep 2022
-
-104.97%(-43.6%)
Jun 2022
-
-73.09%(-34.3%)
Mar 2022
-
-54.44%(+17.3%)
Dec 2021
-49.57%(+29.3%)
-65.85%(+14.8%)
Sep 2021
-
-77.31%(+9.4%)
Jun 2021
-
-85.34%(-6.1%)
Mar 2021
-
-80.41%(-35.2%)
Dec 2020
-70.15%(+9.2%)
-59.46%(+3.1%)
Sep 2020
-
-61.36%(-18.0%)
Jun 2020
-
-51.99%(+14.3%)
Mar 2020
-
-60.67%(+10.2%)
Dec 2019
-77.29%(-94.5%)
-67.54%(-11.4%)
Sep 2019
-
-60.63%(-2.5%)
Jun 2019
-
-59.18%(-32.0%)
Mar 2019
-
-44.83%(+2.5%)
Dec 2018
-39.74%(-341.6%)
-45.96%(-35.1%)
Sep 2018
-
-34.01%(-5.0%)
Jun 2018
-
-32.39%(-16.9%)
Mar 2018
-
-27.71%(-187.4%)
Dec 2017
-9.00%(+91.1%)
-9.64%(+62.3%)
Sep 2017
-
-25.59%(+31.0%)
Jun 2017
-
-37.09%(+13.7%)
Mar 2017
-
-43.00%(+61.5%)
Dec 2016
-101.42%(-0.9%)
-111.73%(+9.8%)
Sep 2016
-
-123.90%(+23.2%)
Jun 2016
-
-161.41%(-21.1%)
Mar 2016
-
-133.29%(-12.4%)
Dec 2015
-100.47%(-83.1%)
-118.63%(-21.5%)
Sep 2015
-
-97.62%(-32.3%)
Jun 2015
-
-73.78%(-10.3%)
Mar 2015
-
-66.91%(-29.1%)
Dec 2014
-54.88%(+9.1%)
-51.83%(-35.5%)
Sep 2014
-
-38.26%(+24.7%)
Jun 2014
-
-50.81%(+6.9%)
Mar 2014
-
-54.59%(+22.6%)
Dec 2013
-60.39%(+61.5%)
-70.52%(+53.7%)
Sep 2013
-
-152.37%(+44.0%)
Jun 2013
-
-271.87%(+9.3%)
Mar 2013
-
-299.83%(+7.7%)
Dec 2012
-156.81%(-853.8%)
-324.90%(-1.5%)
Sep 2012
-
-320.03%(-470.1%)
Jun 2012
-
-56.14%(+42.0%)
Mar 2012
-
-96.82%(-702.2%)
Dec 2011
-16.44%
-12.07%(+80.5%)
Sep 2011
-
-61.82%(+52.1%)
Jun 2011
-
-128.94%(+70.4%)
DateAnnualQuarterly
Mar 2011
-
-435.34%(-53.9%)
Dec 2010
-309.20%(-141.9%)
-282.80%(-113.3%)
Sep 2010
-
-132.61%(+4.1%)
Jun 2010
-
-138.29%(-4.0%)
Mar 2010
-
-133.02%(+9.5%)
Dec 2009
-127.83%(-12.4%)
-147.06%(+22.8%)
Sep 2009
-
-190.57%(-9.7%)
Jun 2009
-
-173.66%(-241.4%)
Mar 2009
-
-50.86%(+57.3%)
Dec 2008
-113.75%(-34.2%)
-119.19%(+11.5%)
Sep 2008
-
-134.73%(-4.1%)
Jun 2008
-
-129.47%(+12.3%)
Mar 2008
-
-147.63%(-35.0%)
Dec 2007
-84.78%(-24.7%)
-109.38%(+0.8%)
Sep 2007
-
-110.26%(-25.8%)
Jun 2007
-
-87.64%(-23.0%)
Mar 2007
-
-71.23%(-12.8%)
Dec 2006
-68.01%(-63.0%)
-63.17%(-13.8%)
Sep 2006
-
-55.52%(-17.7%)
Jun 2006
-
-47.19%(-6.6%)
Mar 2006
-
-44.26%(-5.6%)
Dec 2005
-41.73%(+41.3%)
-41.91%(+13.6%)
Sep 2005
-
-48.53%(+17.1%)
Jun 2005
-
-58.55%(+7.5%)
Mar 2005
-
-63.27%(+8.2%)
Dec 2004
-71.14%(-62.8%)
-68.94%(-13.4%)
Sep 2004
-
-60.78%(-6.2%)
Jun 2004
-
-57.22%(-9.6%)
Mar 2004
-
-52.23%(-14.1%)
Dec 2003
-43.71%(+59.8%)
-45.76%(+16.1%)
Sep 2003
-
-54.57%(+14.4%)
Jun 2003
-
-63.73%(+27.0%)
Mar 2003
-
-87.27%(+8.5%)
Dec 2002
-108.70%(-29.0%)
-95.42%(-3.1%)
Sep 2002
-
-92.55%(+16.4%)
Jun 2002
-
-110.77%(-18.7%)
Mar 2002
-
-93.32%(-12.3%)
Dec 2001
-84.27%(-106.3%)
-83.07%(-11.7%)
Sep 2001
-
-74.40%(-86.2%)
Jun 2001
-
-39.95%(+9.9%)
Mar 2001
-
-44.32%(-5.8%)
Dec 2000
-40.84%(+48.5%)
-41.89%(+22.3%)
Sep 2000
-
-53.92%(+41.4%)
Jun 2000
-
-91.97%(-1.3%)
Mar 2000
-
-90.79%(+19.9%)
Dec 1999
-79.24%(+59.5%)
-113.39%(+1.4%)
Sep 1999
-
-114.96%(+59.4%)
Jun 1999
-
-283.06%(-25.5%)
Mar 1999
-
-225.46%(-19.6%)
Dec 1998
-195.69%(-503.4%)
-188.47%(-20.7%)
Sep 1998
-
-156.13%(-465.3%)
Jun 1998
-
-27.62%(+10.0%)
Mar 1998
-
-30.68%(-27.1%)
Dec 1997
-32.43%(+39.8%)
-24.13%(-17.1%)
Sep 1997
-
-20.60%(-14.6%)
Jun 1997
-
-17.98%(+88.0%)
Mar 1997
-
-150.00%
Dec 1996
-53.85%
-

FAQ

  • What is Sarepta Therapeutics, Inc. annual return on equity?
  • What is the all-time high annual ROE for Sarepta Therapeutics, Inc.?
  • What is Sarepta Therapeutics, Inc. annual ROE year-on-year change?
  • What is Sarepta Therapeutics, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for Sarepta Therapeutics, Inc.?
  • What is Sarepta Therapeutics, Inc. quarterly ROE year-on-year change?

What is Sarepta Therapeutics, Inc. annual return on equity?

The current annual ROE of SRPT is 19.71%

What is the all-time high annual ROE for Sarepta Therapeutics, Inc.?

Sarepta Therapeutics, Inc. all-time high annual return on equity is 19.71%

What is Sarepta Therapeutics, Inc. annual ROE year-on-year change?

Over the past year, SRPT annual return on equity has changed by +105.86% (+122.88%)

What is Sarepta Therapeutics, Inc. quarterly return on equity?

The current quarterly ROE of SRPT is -20.67%

What is the all-time high quarterly ROE for Sarepta Therapeutics, Inc.?

Sarepta Therapeutics, Inc. all-time high quarterly return on equity is 20.83%

What is Sarepta Therapeutics, Inc. quarterly ROE year-on-year change?

Over the past year, SRPT quarterly return on equity has changed by -33.15% (-265.62%)
On this page